BioCryst starts phase I pharmacokinetic study of Fodosine
Fodosine (forodesine hydrochloride) is a transition state purine nucleoside phosphorylase (PNP) inhibitor, which functions by blocking the DNA synthesis machinery of the body’s T-cells. The small molecule drug